Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Visgeneer Inc. (4197:TWSE), powered by AI.
Visgeneer Inc. is currently trading at $8.60. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Visgeneer Inc. on Alpha Lenz.
View Visgeneer Inc.'s valuation metrics on Alpha Lenz.
“Visgeneer Inc.'s ROE is 2.7%. Explore profitability and growth together.”
Ask for details →Visgeneer Inc. is a Taiwanese biotechnology company specializing in the development and manufacture of medical diagnostics and advanced skincare products. Established in 2005 and headquartered in Hsinchu, the company serves the global healthcare, medical device, and beauty markets. Its primary offerings include blood diagnostic equipment—such as glucose, cholesterol, ketone, and uric acid monitors—and test strips, recognized for their comprehensive features and international certifications (including CE, US FDA, ISO13485, and ISO15197), supporting both clinical and consumer health management. Visgeneer’s portfolio also extends to patented EU skincare solutions featuring zeaxanthin for anti-aging, and gene-based cancer diagnostics leveraging proprietary bioinformatics technology. With a notable presence across Asia, Europe, and other regions, Visgeneer supports hospitals, research institutions, and pharmaceutical distributors, and provides OEM and ODM contract manufacturing services. Awarded by Taiwan’s government for strategic innovation, Visgeneer continually contributes to global health solutions through product development and industry collaborations, solidifying its role as a leader in medical equipment and bioscience advancements.
“Visgeneer Inc.'s ROE is 2.7%. Explore profitability and growth together.”
Ask for details →Visgeneer Inc. (ticker: 4197) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 8.6 with a P/E ratio of -x and P/B of -x.
ROE is 2.67% and operating margin is -3.02%. Annual revenue is $179M.